NancyTSklarinMDMasters in Management

PubMed

• 1 citations
  Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.
  Idil Eroglu, Olga T Filippova, Maria Kirrane, Mary Orpen, Vianca Almonte, Rachel Thomas, Melissa Lee-Teh, Richard Tizon, Nancy Sklarin, Roisin O'Cearbhaill> ;International Journal of Gynecological Cancer. 2022 Jun 8
• 11 citations
  A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
  Komal Jhaveri, Joshua Z. Drago, Payal D. Shah, Rui Wang, Fresia Pareja, Fanni Ratzon, Alexia Iasonos, Sujata Patil, Neal Rosen, Monica Fornier, Nancy Sklarin, Sarat Ch...> ;Clinical Cancer Research. 2021 May 4
• 27 citations
  Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
  Patrick G. Morris, Selene Rota, Karen Cadoo, Stephen Zamora, Sujata Patil, Gabriella D'Andrea, Theresa Gilewski, Jacqueline Bromberg, Chau T. Dang, Maura N. Dickler, S...> ;Clinical Breast Cancer. 2018 Oct 1
• 17 citations
  Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia.
  Viswanath Reddy Belum, Giselle de Barros Silva, Mariana Tosello Laloni, Kathryn Ciccolini, Shari Goldfarb, Larry Norton, Nancy Sklarin, Mario E. Lacouture> ;Breast Cancer Research and Treatment. 2016 May 5
• 73 citations
  Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
  Conleth G. Murphy, Divya Mallam, Samantha Stein, Sujata Patil, Jane Howard, Nancy Sklarin, Clifford A. Hudis, Mary L. Gemignani, Andrew D. Seidman> ;Cancer. 2012 Jul 1
• 44 citations
  A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
  Monica Fornier, Patrick G. Morris, A. Abbruzzi, Gabriella D'Andrea, Teresa Gilewski, Jacqueline Bromberg, Chau T. Dang, Maura N. Dickler, Shanu Modi, Andrew D. Seidman...> ;Annals of Oncology. 2011 Dec 1
• 12 citations
  Electronic Chemotherapy Order Entry: A Major Cancer Center's Implementation.
  Nancy T. Sklarin, Svetlana Granovsky, Eileen M. O'Reilly, Andrew D. Zelenetz> ;Journal of Oncology Practice. 2011 Jul 1
• TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).
  Gucalp A, Tolaney SM, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo HS, Nabell L, Abbruzzi A, Gonzalez J, Giri DD, Patil S, Feigin K, D'Andrea G, Theodoul...> ;J. Clin. Oncol.. 2011-05-20
• Incidence of hypersensitivity reactions (HSRs) to albumin-bound paclitaxel (ABI) in patients (pts) with a history of HSR to cremophor-based paclitaxel (P).
  Timoney JP, McGuffy D, DeRitis D, Tyler E, Sumka J, Pozotrigo M, Bhatt V, Chan A, Sklarin NT> ;J. Clin. Oncol.. 2011-05-20
• 25 citations
  A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer
  Heather L. McArthur, Hope S. Rugo, B. Nulsen, Laura Hawks, Jill Grothusen, Michelle E. Melisko, Mark M. Moasser, Matthew Paulson, Tiffany A. Traina, Sujata Patil, Qin ...> ;Clinical Cancer Research. 2011 May 15
• 4 citations
  Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
  Pamela Drullinsky, Steven Sugarman, Monica Fornier, Gabriella D'Andrea, Teresa Gilewski, Diana Lake, Tiffany A. Traina, Carolyn Wasserheit-Lieblich, Nancy Sklarin, Dee...> ;Clinical Breast Cancer. 2010 Dec 1
• 49 citations
  The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast Cancer
  Chau T. Dang, Monica Fornier, Steven Sugarman, Tiffany A. Troso-Sandoval, Diana Lake, Gabriella D'Andrea, Andrew D. Seidman, Nancy Sklarin, Maura N. Dickler, Violante ...> ;Journal of Clinical Oncology. 2008 Mar 10
• 45 citations
  Bevacizumab 5 mg/kg Can Be Infused Safely Over 10 Minutes
  Diane Lauren Reidy, Ki Y. Chung, John P. Timoney, Vivian Park, Ellen Hollywood, Nancy Sklarin, Raymond J. Muller, Leonard B. Saltz> ;Journal of Clinical Oncology. 2007 Jul 1
• Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/ampli...
  Smith CD, Fornier M, Sugarman S, Troso-Sandoval T, Lake D, D'Andrea G, Seidman A, Sklarin N, Norton L, Hudis C> ;J. Clin. Oncol.. 2006-06-20
• Serum peptide profiling (SPP) by mass spectrometry (MS) to identify post-menopausal women with metastatic breast cancer.
  Smith KL, Villanueva J, D'Andrea G, Moynahan ME, Sklarin N, Norton L, Hudis C, Tempst P, Robson M> ;J. Clin. Oncol.. 2005-06-01
• MSKCC Quality Assessment (QA) monitoring program for potentially harmful chemotherapy orders.
  Sklarin NT, Timoney J, Kampel L, Hydzik C, Savage J, Capobianco M, Miransky J, Haspel J> ;J. Clin. Oncol.. 2004-07-15
• 8 citations
  Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome.
  Anna York P. Bondoc, Peter B. Bach, Nancy Sklarin, Nicholas Vander Els> ;Cancer Investigation. 2003 Oct 12
• 13 citations
  Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy
  John P. Timoney, Mary M Eagan, Nancy Sklarin> ;Journal of Nursing Care Quality. 2003 Jan 1
• 27 citations
  Doxorubicin Followed by Sequential Paclitaxel and Cyclophosphamide versus Concurrent Paclitaxel and Cyclophosphamide: 5-Year Results of a Phase II Randomized Trial of ...
  Monica Fornier, Andrew D. Seidman, Maria Theodoulou, Mary Ellen Moynahan, Violante Currie, Mark M. Moasser, Nancy Sklarin, Theresa Gilewski, Gabriella D'Andrea, Rori S...> ;Clinical Cancer Research. 2001 Dec 1
• 428 citations
  Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification
  Andrew D. Seidman, Monica Fornier, Francisco J. Esteva, Lee Tan, Stamatina Kaptain, Ariadne M. Bach, Katherine S. Panageas, Crispinita D. Arroyo, Vicente Valero, Viola...> ;Journal of Clinical Oncology. 2001 May 15
• 159 citations
  Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial
  Catherine Van Poznak, Andrew D. Seidman, Marcus M. Reidenberg, Mark M. Moasser, Nancy Sklarin, Kimberly J. Van Zee, Patrick I. Borgen, Marc J. Gollub, Doreen Bacotti, ...> ;Breast Cancer Research and Treatment. 2001 Apr 1
• 100 citations
  Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT.
  Corinne B. Winston, Orna Hadar, Jerrold Teitcher, James F. Caravelli, Nancy T. Sklarin, David M. Panicek, Laura Liberman> ;AJR. American Journal of Roentgenology. 2000 Sep 1
• 47 citations
  5-Year Results of Dose-Intensive Sequential Adjuvant Chemotherapy for Women With High-Risk Node-Positive Breast Cancer: A Phase II Study
  Clifford A. Hudis, Monica Fornier, L. Riccio, David Lebwohl, John Crown, Teresa Gilewski, Antonella Surbone, Violante Currie, Andrew D. Seidman, Bonnie Reichman, ME Mo...> ;Journal of Clinical Oncology. 1999 Apr 1
• 9 citations
  Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer
  Gabriella D'Andrea, David Fennelly, Larry Norton, José Baselga, Teresa Gilewski, Clifford A. Hudis, Mary Ellen Moynahan, George Raptis, Nancy Sklarin, Antonella Surbon...> ;Clinical Cancer Research. 1999 Feb 1
• 89 citations
  Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy
  Clifford A. Hudis, Andrew D. Seidman, José Baselga, George Raptis, David Lebwohl, Teresa Gilewski, ME Moynahan, Nancy Sklarin, David Fennelly, John Crown, Antonella Su...> ;Journal of Clinical Oncology. 1999 Jan 1
• Join now to see all